The primary regulator of dopamine availability in the brain is the dopamine transporter
(DAT), a plasma membrane protein that drives reuptake of released dopamine from the …

Aberrant dopamine (DA) signalling has been implicated in various neuropsychiatric
disorders, including attention‐deficit/hyperactivity disorder (ADHD), autism spectrum …

The nanoscopic organization and regulation of individual molecular components in
presynaptic varicosities of neurons releasing modulatory volume neurotransmitters like …

Following its evoked release, dopamine (DA) signaling is rapidly terminated by presynaptic
reuptake, mediated by the cocaine-sensitive DA transporter (DAT). DAT surface availability …

Aberrant dopamine (DA) signaling is implicated in schizophrenia, bipolar disorder (BPD),
autism spectrum disorder (ASD), substance use disorder, and attention-deficit/hyperactivity …

The dopamine transporter (DAT) is critical for spatiotemporal control of dopaminergic
neurotransmission and is the target for therapeutic agents, including ADHD medications …

The membrane dopamine transporter (DAT) is involved in a number of brain disorders and
its exploration by positron emission tomography (PET) imaging is highly relevant for the …

Causal factors of psychiatric diseases are unclear, due to gene× environment interactions.
Evaluation of consequences, after a dopamine-transporter (DAT) gene knock-out (DAT-KO) …

Semiconductor quantum dots (QDs) have demonstrated utility in long-term single particle
tracking of membrane proteins in live cells in culture. To extend the superior optical …

Abstract Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in
social salience and motivation. Clinical trials of the efficacy of OT in autism spectrum …